Projects per year
Fingerprint Dive into the research topics where Carlos Graux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 17 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Etude miR-126 impliqué en oncogenèse
MUYLKENS, B., Graux, C., GEORGE, F. & Finet, L.
1/12/13 → …
Project: Research
Test sanguin de détection/pronostic de cancer
POPA, C., De Ronde, T., Rahier, J., D'Hondt, L., Graux, C., GEORGE, F., Finet, L. & Herzog, M.
1/12/13 → …
Project: Research
Etude de l’effet potentiel de macrophages sur la cytotoxicité de molécules chimiothérapeutiques vis-à-vis de cellules cancéreuses
Graux, C., MICHIELS, C. & GENIN, M.
1/12/13 → 30/09/14
Project: Research
Télévie: Etude de la résistance des tumeurs aux agents utilisés en chimiothérapie : caractérisation et validation d’un gène candidat
MICHIELS, C., Graux, C., D'Hondt, L., GEORGE, F. & Finet, L.
1/12/13 → 30/09/16
Project: Research
Research Output
Evaluation of the Selectivity of BCR-ABL Tyrosine Kinase Inhibitors (TKIs): A Systematic Review
Haguet, H., Challe, C., Nezzar, Y., MULLIER, F., Graux, C., DOGNE, J-M. & DOUXFILS, JONATHAN., 12 Jul 2020.Research output: Contribution to conference › Poster
In vitro Evaluation of the Impact of BCR-ABL Tyrosine Kinase Inhibitors on Atherosclerosis Plaque Rupture
Haguet, H., MULLIER, F., Graux, C., DOGNE, J-M. & DOUXFILS, JONATHAN., 12 Jul 2020.Research output: Contribution to conference › Poster
In vitro investigation of the impact of BCR-ABL Tyrosine Kinase Inhibitors on endothelial cells
Haguet, H., MULLIER, F., Graux, C., DOGNE, J-M. & DOUXFILS, JONATHAN., 12 Jul 2020.Research output: Contribution to conference › Poster
Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis
Haguet, H., Graux, C., Mullier, F., Dogné, J-M. & Douxfils, J., 15 May 2020, In : Cancers. 12, 5, 15 p., 1242.Research output: Contribution to journal › Article
File
An updated meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukemia
Haguet, H., Mullier, F., Graux, C., Dogne, J-M. & Douxfils, J., 13 Jun 2019.Research output: Contribution to conference › Poster
Datasets
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), CHATELAIN, C. (Contributor), MULLIER, F. (Contributor), Haguet, H. (Contributor), DOGNE, J. (Contributor) & DOUXFILS, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Activities
- 6 Oral presentation
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
21 Mar 2019
Activity: Talk or presentation types › Oral presentation
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), , François Mullier (Speaker), & Jean-Michel Dogne (Speaker)
9 Feb 2018
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
25 Feb 2017
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
28 Apr 2016
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
29 Jan 2016
Activity: Talk or presentation types › Oral presentation
Press / Media
Volition Creates Clinical Evaluation Committee
14/11/11 → 16/11/11
2 items of Media coverage
Press/Media: Expert Comment